Gene: FGFR1OP2
Official Full Name: FGFR1 oncogene partner 2provided by HGNC
Gene Summary: Predicted to enable identical protein binding activity. Predicted to be involved in response to wounding. Predicted to act upstream of or within wound healing. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28302 | FGFR1OP2 Knockout cell line (HeLa) | Human | FGFR1OP2 | 1:3~1:6 | Negative | Online Inquiry |
KO28303 | FGFR1OP2 Knockout cell line (HCT 116) | Human | FGFR1OP2 | 1:2~1:4 | Negative | Online Inquiry |
KO28304 | FGFR1OP2 Knockout cell line (HEK293) | Human | FGFR1OP2 | 1:3~1:6 | Negative | Online Inquiry |
KO28305 | FGFR1OP2 Knockout cell line (A549) | Human | FGFR1OP2 | 1:3~1:4 | Negative | Online Inquiry |
FGFR1OP2 Gene Knockout Cell Lines are engineered human cell lines in which the FGFR1OP2 gene has been specifically targeted and inactivated through advanced genomic editing techniques, such as CRISPR-Cas9. The FGFR1OP2 gene, implicated in several cellular processes, notably influences cell proliferation and differentiation by regulating fibroblast growth factor receptor pathways. By knocking out this gene, researchers gain a powerful tool to study its biological roles and contributions to various physiological and pathological conditions.
The key function of FGFR1OP2 knockout cell lines lies in their ability to help elucidate the mechanisms behind diseases associated with aberrant FGFR signaling, including certain cancers and developmental disorders. These cell lines enable researchers to perform functional assays that dissect signaling pathways, allowing for pharmacological interventions to be tested efficiently. Insights gained from these investigations can pave the way for potential therapeutic applications, illustrating the gene's significance in drug discovery and development.
In comparison to traditional knockdown methods, FGFR1OP2 knockout cell lines offer complete gene inactivation, providing a more definitive understanding of gene function without the residual activity that may cloud results in knockdown models. This potency enhances data robustness and reproducibility—crucial elements in preclinical studies.
For researchers and clinicians, these cell lines represent an invaluable resource, facilitating high-throughput screening of drug candidates or genetic interactions in a controlled environment, thus streamlining the translation of basic research into clinical solutions.
Our company specializes in the development of high-quality biological products, leveraging cutting-edge technologies to deliver precision cell lines that meet the evolving needs of the scientific community. With rigorous validation and a commitment to supporting groundbreaking research, our FGFR1OP2 Gene Knockout Cell Lines stand out as an essential tool for advancing scientific inquiry and therapeutic exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.